XML 37 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Organization and Business (Details)
12 Months Ended
Dec. 31, 2021
USD ($)
Center
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2020
Sep. 02, 2017
Dec. 23, 2016
Dec. 31, 2011
Dec. 31, 2010
Equity Method Investments [Abstract]                    
Cash reserves | $ $ 2,178,000 $ 2,567,000 $ 2,820,000 $ 2,543,000 $ 2,030,000          
Corona Gamma Knife, LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage 39.00%                  
Neuro Partners LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage 20.00%                  
Boca Oncology Partners RE, LLC ("BOPRE") [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage 22.50%                  
Medical Oncology Partners LLC [Member]                    
Equity Method Investments [Abstract]                    
Equity interest percentage to be acquired by subsidiary 100.00%                  
CB Oncology Partners LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage           28.58% 24.00%      
NYU [Member]                    
Equity Method Investments [Abstract]                    
Number of gamma knife centers owned | Center 1                  
USNC [Member] | Corona Gamma Knife, LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage 39.00%                  
USNC [Member] | Neuro Partners LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage 20.00%                  
USNC [Member] | Florida Oncology Partners, LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage                   24.00%
USNC [Member] | Boca Oncology Partners RE, LLC ("BOPRE") [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage                 22.51%  
USNC [Member] | Medical Oncology Partners LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage               35.83%    
USNC [Member] | CB Oncology Partners LLC [Member]                    
Equity Method Investments [Abstract]                    
Ownership percentage           28.58%